Evidence map›Paper›PMID 30386106›Full record

ArticleWorld journal of gastroenterology2018

Li-Ping Liu, Xi-Ping Sheng, Tian-Kui Shuai, Yong-Xun Zhao, Bin Li, Yu-Min Li

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. International journal of biological sciences · 2024
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Pathogens (Basel, Switzerland) · 2022
    Article
  12. Current and future perspectives forFrontiers in cellular and infection microbiology · 2022
    Review
  13. Article
  14. Effect of Invasion ofAntibiotics (Basel, Switzerland) · 2021
    Article
  15. The Heparanase Regulatory Network in Health and Disease.International journal of molecular sciences · 2021
    Review
  16. World journal of gastroenterology · 2021
    Review
  17. Article
  18. Article
  19. Frontiers in immunology · 2021
    Article
  20. Serum Heparanase: A New Clinical Biomarker Involved in Senile Metabolic Inflammatory Syndrome.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Li-Ping LiuThe Second Clinical Medical School of Lanzhou University, Lanzhou 730000, Gansu Province, China.
Xi-Ping ShengInstitute of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, Lanzhou 730000, Gansu Province, China.
Tian-Kui ShuaiDepartment of Critical Care Medicine, The Donggang District of First Hospital of Lanzhou University, Lanzhou 730030, Gansu Province, China.
Yong-Xun ZhaoDepartment of Surgical Oncology, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China.
Bin LiDepartment of Critical Care Medicine, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China.
Yu-Min LiKey Laboratory of Digestive System Tumors of Gansu Province, The Second Clinical Medical School of Lanzhou University, Lanzhou 730000, Gansu Province, China. liym@lzu.edu.cn.
First Hospital of Lanzhou University · CNLanzhou University · CNLanzhou University Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo detect the mechanisms of

methodsSpecimens from 99 patients with GC were collected. The correlation among

results

conclusion

Indexed as

AdultAgedCell Line, TumorDisease-Free SurvivalFemaleGastrectomyGlucuronidaseHelicobacter InfectionsHelicobacter pyloriHeparanaseHumansKaplan-Meier EstimateLymphatic MetastasisMaleMiddle AgedMitogen-Activated Protein KinasesGlucuronidaseHeparanaseMitogen-Activated Protein KinasesGastric cancerHelicobacter pyloriHeparanaseMitogen-activated protein kinaseOverall survivalRelapse-free survival

Identifiers

PMID30386106
PMCPMC6209574
OpenAlexW2898546228

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.